These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9198207)

  • 1. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; from homocysteine to hyperhomocysteinemia].
    Boers GH
    Ned Tijdschr Geneeskd; 2001 May; 145(20):956-8. PubMed ID: 11396261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Boers GH
    Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia: a new independent vascular risk factor?].
    Cafagna D; Ponte E
    Minerva Cardioangiol; 1997; 45(1-2):49-55. PubMed ID: 9213816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment.
    Boers G
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S127-30. PubMed ID: 9587040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
    de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
    Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and venous thrombosis.
    Quéré I; Gris JC; Dauzat M
    Semin Vasc Med; 2005 May; 5(2):183-9. PubMed ID: 16047270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and thrombosis.
    Guba SC; Fonseca V; Fink LM
    Semin Thromb Hemost; 1999; 25(3):291-309. PubMed ID: 10443960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; Den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2003 Jan; 11(1):23-9. PubMed ID: 12529702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and venous thrombosis.
    Gatt A; Makris M
    Semin Hematol; 2007 Apr; 44(2):70-6. PubMed ID: 17433898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.